Augmedix (AUGX) Stock Price, News & Analysis

Company Overview

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Key Stats

• Today's Range: $2.35 to $2.35
• 50-Day Range: $2.29 to $2.35
• 52-Week Range: $0.73 to $6.25
• Volume: N/A
• Average Volume: 635,746 shs
• Market Capitalization: $115.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.09
• Consensus Rating: Hold

AUGX Stock Analysis - Frequently Asked Questions

When did Augmedix IPO?

Augmedix (AUGX) raised $40 million in an initial public offering on Tuesday, October 26th 2021. The company issued 10,000,000 shares at a price of $4.00 per share. William Blair, B. Riley Securities, Benchmark and Lake Street acted as the underwriters for the IPO.

Who are Augmedix's major shareholders?

Top institutional shareholders of Augmedix include Trium Capital LLP (2.41%), HGC Investment Management Inc. (1.69%), Geode Capital Management LLC (1.14%) and State Street Corp (0.31%). Insiders that own company stock include Paul Ginocchio, Emmanuel Krakaris, Ian Shakil and Saurav Chatterjee.
View institutional ownership trends.

What other stocks do shareholders of Augmedix own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Augmedix investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Disc Medicine (IRON) and Novo Nordisk A/S (NVO).

Company Calendar

• Today: 11/23/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Business services, not elsewhere classified
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:AUGX
• CUSIP: N/A
• CIK: 1769804
• Web: www.augmedix.com
• Phone: 888-669-4885
• Fax: N/A
• Employees: 1,430
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $3.09
• High Stock Price Target: $5.00
• Low Stock Price Target: $1.50
• Potential Upside/Downside: +31.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.43)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-19,170,000.00
• Net Margins: -46.23%
• Pretax Margin: -46.10%
• Return on Equity: -182.36%
• Return on Assets: -43.21%

Debt

• Debt-to-Equity Ratio: 1.48
• Current Ratio: 1.66
• Quick Ratio: 1.66

Sales & Book Value

• Annual Sales: $51.58 million
• Price / Sales: 2.23
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.56 per share
• Price / Book: 4.20

Miscellaneous

• Outstanding Shares: 48,968,000
• Free Float: 43,596,000
• Market Cap: $115.07 million
• Optionable: Optionable
• Beta: -0.22